ストックスクリーナーアプリを入手
0.3877
9.86%
-0.0422
前日終値:
$0.4299
開ける：
$0.421
24時間の取引高:
2.24M
Relative Volume:
0.36
時価総額：
$39.05M
収益：
$69.49M
当期純損益:
$-21.13M
株価収益率:
-0.5974
EPS:
-0.649
ネットキャッシュフロー:
$-14.46M
1週間 パフォーマンス:
+1.95%
1か月 パフォーマンス:
+70.03%
6か月 パフォーマンス:
+21.44%
1年 パフォーマンス:
-64.77%
1日の値動き範囲:
$0.364
$0.421
1週間の範囲:
$0.35
$0.44
52週間の値動き範囲:
$0.1616
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
名前
Cosmos Health Inc
セクター
電話
312-536-3102
住所
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.388 | 35.38M | 69.49M | -21.13M | -14.46M | -0.649 |
MCK
Mckesson Corp
|
891.02 | 101.04B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
309.78 | 58.57B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
229.14 | 50.99B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.83 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.9998 | 642.53M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc (COSM) 最新ニュース
Why Did SOC, HTZ, COSM Stocks Tumble To 52-Week Lows? - Stocktwits
Cosmos Health stock gains 14.79 percent after record revenue - AD HOC NEWS
Cosmos Health stock trades at USD 0.44 as filings remain central - AD HOC NEWS
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June - ACCESS Newswire
Cosmos Health stock moves on CCX0722 IP tokenization plan - AD HOC NEWS
Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway - Newswire.com
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market - New Castle News
Cosmos Health subsidiary secures 5.2M unit manufacturing deal - Investing.com
Cosmos Health subsidiary secures 5.2M unit manufacturing deal By Investing.com - Investing.com India
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma - FinancialContent
Cosmos Health engages Prime Ledger for tokenized IP financing - Investing.com
Cosmos Health engages Prime Ledger for tokenized IP financing By Investing.com - Investing.com India
A weight-management capsule’s gel expands more than 100-fold. Cosmos Health proposes funding it without new shares. - Stock Titan
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com South Africa
Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar - TradingView
COSM Looks 10.4% Undervalued on GF Value™ Amid Contract Manufact - GuruFocus
Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine - Bitget
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units - ACCESS Newswire
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market - webull.com
Cosmos Health receives first orders for veterinary product line By Investing.com - Investing.com Nigeria
COSM Looks 8.2% Undervalued on GF Value™ Amid Challenging Fundam - GuruFocus
Cosmos Health receives first orders for veterinary product line - Investing.com
Cosmos Health buyback reaches 5.11 million shares under $5 million program - scanx.trade
Cosmos Health reports record revenue, retires $8M debt early By Investing.com - Investing.com Australia
Cosmos Health: A Company Transformed — 2026 Y - Moomoo
Cosmos Health Reaffirms 2029 Guidance - TradingView
Cosmos Health Q2FY26 Results: Revenue up 28.8% to $18.99M - scanx.trade
Cosmos Health reports record revenue, retires $8M debt early - Investing.com
Cosmos Health Inc. - Via Ritzau
Press Release: Cosmos Health: A Company Transformed -- 2026 Year-to-Date - Moomoo
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure, Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution from Conversions - marketscreener.com
Cosmos Health stock rises after $8 million note retirement - AD HOC NEWS
Cosmos Health retires $8M convertible note early By Investing.com - Investing.com UK
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions - kommunikasjon.ntb.no
COSMOS HEALTH INC: OPERATING CASH REQUIREMENTS REDUCED BY MORE THAN 30% - Moomoo
Cosmos Health projects $6M revenue from Oliv18 supplement launch - Investing.com India
COSM Looks 33.4% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus
Cosmos Health projects $6M revenue from Oliv18 supplement launch By Investing.com - Investing.com Nigeria
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories - Barchart.com
Weekly Recap: Cosmos Health Q2 revenue gains and five‑year Innova Saudi deal - TradingView
Cosmos Health Inc. Projects Over $6 Million in Annual U.S. Revenue for Oliv18™ in 12 to 18 Months - Quiver Quantitative
Cosmos Health C-Sept PRO sales exceed $1.3 million at 72% margin - scanx.trade
Is Cosmos Health Inc (COSM) Undervalued After Q2 Earnings Miss? GF Score: 29/100, Revenue at $18.99 Million - GuruFocus
Cosmos Reports Record Q2: Revenue $19.0M, H1 $36.9M; Adjusted Gross Profit Up 58% - TradingView
Cosmos Health Company Profile & Introduction - Moomoo
COSM Looks 40.0% Undervalued on GF Value™ Amid Distribution Deal - GuruFocus
Cosmos Health signs exclusive Saudi distribution deal for supplements By Investing.com - Investing.com South Africa
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare - TradingView
Cosmos Health signs exclusive Saudi distribution deal for supplements - Investing.com
Cosmos Health Inc (COSM) 財務データ
収益
当期純利益
現金流量
EPS
Cosmos Health Inc (COSM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jul 29 '26 |
Buy |
0.18 |
766,284 |
140,000 |
14,248,092 |
| Terzis Georgios | Chief Financial Officer |
Jun 16 '26 |
Buy |
0.25 |
168,135 |
42,000 |
2,235,398 |
| Siokas Grigorios | Chief Executive Officer |
Jun 11 '26 |
Buy |
0.21 |
218,447 |
45,000 |
13,481,808 |
| Siokas Grigorios | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.23 |
701,447 |
160,000 |
13,263,361 |
| Siokas Grigorios | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.37 |
388,532 |
145,000 |
8,861,914 |
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
1.30%
4.01%
大文字化:
|
ボリューム (24 時間):